基本信息
浏览量:6
职业迁徙
个人简介
Over the last 30 years, he has been involved in clinical research in chronic lymphocytic leukemia (CLL). During this time the complete remission rate has risen dramatically from approximately 5% to 50 – 60%. This is associated with improvements in developmental therapeutic programs but also a dramatic improvement in the understanding of the biology and prognostic factors of CLL. CLL is a disease of the elderly and the characterization of other cancers in survivors of CLL is vitally important. Understanding of this comparison between incidence and characteristics of other cancers in CLL survivors is vitally important in its own right but must be integrated into clinical understanding of the disease. He is totally committed to providing clinical and intellectual resources at his disposal to support the program.
研究兴趣
论文共 915 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCERno. 14 (2023): 2192-2200
Leukemiano. 7 (2023): 1444-1453
Uri Rozovski, Srdana Grgurevic,Carlos Bueso-Ramos,David M. Harris,Ping Li,Zhiming Liu,Ji Yuan Wu,Preetesh Jain,William Wierda,Jan Burger, Susan O'Brien,Nitin Jain,
crossref(2023)
BLOOD (2023)
Ivo Veletic,David M. Harris,Uri Rozovski,Ping Li,Zhiming Liu,Taghi Manshouri, Maria Teresa S. Bertilaccio,George A. Calin, Rares-Constantin Drula,Koichi Takahashi,Ken Furudate,Muharrem Muftuoglu,
BLOOD (2023): 3264
BLOOD (2023)
Blood (2023): 4635
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn